-

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Trip.com Group Limited (TCOM) Shareholders To Inquire About Securities Fraud Class Action

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Trip.com Group Limited (“Trip.com” or the “Company”) (NASDAQ: TCOM) securities between April 30, 2024 and January 13, 2026, inclusive (the “Class Period”). Trip.com investors have until May 11, 2026 to file a lead plaintiff motion.

IF YOU SUFFERED A LOSS ON YOUR TRIP.COM GROUP LIMITED (TCOM) INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS

What Happened?

On January 14, 2026, Bloomberg published an article revealing that “China is investigating [Trip.com] over alleged antitrust conduct,” and the “State Administration for Market Regulation accused [Trip.com] of abusing its market position and engaging in monopolistic practices.

The article further revealed that, in September 2025, the market regulator had “summoned Trip.com for violations of rules against setting ‘unfair restrictions’ on merchants’ transactions and prices.”

On this news, Trip.com’s stock price fell $12.90, or 17.05%, to close at $62.78 per share on January 14, 2026, thereby injuring investors.

What Is The Lawsuit About?

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Defendants recklessly understated the regulatory risk facing Trip.com as a result of its monopolistic business activities; and (2) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased or otherwise acquired Trip.com securities during the Class Period, you may move the Court no later than May 11, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.

Contact Us To Participate or Learn More:

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: shareholders@glancylaw.com
Telephone: 310-201-9150,
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.

If you inquire by email, please include your mailing address, telephone number and number of shares purchased.

To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email: shareholders@glancylaw.com
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

Glancy Prongay Wolke & Rotter LLP

NASDAQ:TCOM

Release Versions

Contacts

Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email: shareholders@glancylaw.com
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

More News From Glancy Prongay Wolke & Rotter LLP

Deadline Alert: Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: SLNO) common stock between March 26, 2025 and November 4, 2026, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR SOLENO INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING...

Securities Fraud Investigation Into ChowChow Cloud International Holdings Limited (CHOW) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ChowChow Cloud International Holdings Limited (“CHOW” or the “Company”) (NYSE: CHOW) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CHOWCHOW CLOUD INTERNATIONAL HOLDINGS LIMITED (CHOW), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUIN...

Securities Fraud Investigation Into Medical Properties Trust, Inc. (MPT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Medical Properties Trust, Inc. (“Medical Properties” or the “Company”) (NYSE: MPT) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON MEDICAL PROPERTIES TRUST, INC. (MPT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVE...
Back to Newsroom